3Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines[J]. Hepatology,2000,31:1005-1013.
4Leuschner M,Dietrich C-F,You T,et al.Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment[J].Gut ,2000;46:121-126.
二级参考文献2
1Dr. T. Maeda MD,S. Onishi MD,T. Miura MD,S. Iwamura MD,A. Tomita MD,T. Saibara MD,Y. Yamamoto MD. Exacerbation of primary biliary cirrhosis during interferon-α2b therapy for chronic active hepatitis C[J] 1995,Digestive Diseases and Sciences(6):1226～1230
3Xiao-Hua Jiang,Xiao-Yun Fang,Ren-Qian Zhong,Xiu-Ping Wang,Yin Hu,Xian-Tao Kong the Department of Laboratory Medicine, 85th Military Hospital, Shanghai 200052, China People’s Liberation Army Clinical Immunology Center, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China Shanghai University of Engineering Science, Shanghai 200335..Development of an enzyme immune assay for detecting M2 autoantibodies specific for primary biliary cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2003,2(2):606-610. 被引量：1
